Skip to main content

GILD

Gilead Sciences, Inc.

Company with tickers: GILD

CIK
882095
CUSIP
375558103
Shares Outstanding
1,241,569,874
13F Activity (30d)
339 filings 298 filers

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$5,000,000,000
as of 2014-09-30 · not restated in filings since 2014-11-05
Remaining Authorization
$5,700,000,000
as of 2022-09-30 · not restated in filings since 2022-11-02
Fiscal Year Ended Cash Spent
2026-03-31 YTD $419,000,000
2025-12-31 $1,922,000,000
2024-12-31 $1,150,000,000
2023-12-31 $1,000,000,000
2022-12-31 $1,396,000,000
2021-12-31 $546,000,000
2020-12-31 $1,583,000,000
2019-12-31 $1,749,000,000
2018-12-31 $2,900,000,000
2017-12-31 $954,000,000
2016-12-31 $11,001,000,000
2015-12-31 $10,002,000,000
2014-12-31 $5,349,000,000
2013-12-31 $582,000,000
2012-12-31 $667,000,000
2011-12-31 $2,383,132,000
2010-12-31 $4,022,593,000
2009-12-31 $998,495,000
2008-12-31 $1,969,582,000
2007-12-31 $487,543,000

Recent quarters

Quarter Ended Cash Spent
2026-03-31 $419,000,000
2025-12-31 $230,000,000 Δ
2025-09-30 $435,000,000 Δ
2025-06-30 $527,000,000 Δ
2025-03-31 $730,000,000
2024-12-31 $350,000,000 Δ
2024-09-30 $300,000,000 Δ
2024-06-30 $100,000,000 Δ
2024-03-31 $400,000,000
2023-12-31 $150,000,000 Δ
2023-09-30 $300,000,000 Δ
2023-06-30 $150,000,000 Δ